Bloomsbury, NJ
May 19, 2008
Avant Immunotherapeutics' 1st-quarter loss widens on charge for acquired in-process research
Biotechnology company Avant Immunotherapeutics Inc. said Monday its first-quarter loss widened on buyout charges. via Canadian Business Magazine
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Diner passes on ex-Perkins site | 13 min | Floyd | 3 |
| Morning Call faces large-scale cuts | 41 min | elektra | 230 |
| Police Blotter | 1 hr | Toni | 1 |
| Alleged Easton crack dealer arrested in N.Y. | 6 hr | Moronic Dems | 23 |
| Morning Call announces cuts | 6 hr | User1805 | 44 |
| Parking garage may help offset cash woes | 14 hr | Redneck Hunter | 1 |
| Bald eagle nearly electrocuted in West Easton | 14 hr | John | 21 |
58°F
Most Popular
